![oral glp-1 analogues Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] The challenge of developing oral](https://www.preprints.org/frontend/picture/ms_xml/manuscript/7be468775bea75bf2036c55c34b8f0dc/preprints-159314-g002.png)
oral glp-1 analogues Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] The challenge of developing oral
Description
2022 Sep
![oral glp-1 analogues Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] The challenge of developing oral](https://d2cbg94ubxgsnp.cloudfront.net/Pictures/web/p/u/k/glp1_agonists__oral_166359.svgz)
Why this matters
![oral glp-1 analogues Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] The challenge of developing oral](https://www.apexanesthesia.com/wp-content/uploads/2024/05/article_GLP1_organ_effects.jpg)
Additionally, the increase in microvascular blood flow in muscles contributes to reduced intramuscular fat accumulation and alleviation of myosteatosis, while AMPK pathway-mediated increased fat oxidation supports the mobilization of intramuscular fat, allowing for improvements in energy metabolism and reduction of fat within muscle tissue [39]
![oral glp-1 analogues Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] The challenge of developing oral](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-01750-0/MediaObjects/41598_2021_1750_Fig1_HTML.png)
The injection Treatment Effect in People with Obesity (STEP) clinical trial program is a notable example of clinical studies supporting the effectiveness of semaglutide in weight loss
![oral glp-1 analogues Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] The challenge of developing oral](https://www.nejm.org/cms/asset/5dbb8386-970e-40cd-8975-ee30ec45fd1e/media/NEJMdo008155_300x200.jpg)
The other loses a larger proportion of muscle along with fat
![oral glp-1 analogues Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] The challenge of developing oral](https://www.docseducation.com/sites/default/files/inline-images/Screen%20Shot%202024-02-23%20at%2011.33.14%20AM_0.png)
